未找到相关数据
A phase Ib extension study of cancer sternness inhibitor BB608 (napabucasin) in combination with gemcitabine and nab-paclitaxel (nab-PTX) in patients (pts) with metastatic pancreatic cancer.
被引：6
作者：
El-Rayes, Bassel F.
Shanda, Safi
Starodub, Alexander
O'Neil, Bert H.
Hanna, Wahid Tewfik
Shaib, Walid Labib
Oh, Cindy
Li, Wei
Li, Youzhi
Borodyansky, Laura
Li, Chiang
Bekaii-Saab, Tanios S.
机构：
[1] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
[3] Indiana Univ, Hlth Goshen Ctr Canc Care, Bloomington, IN 47405 USA
[4] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Univ Tennessee, Med Ctr, Knoxville, TN USA
[6] Boston Biomed Inc, Boston, MA USA
[7] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词：
D O I：
10.1200/JCO.2016.34.15_supp1.4128
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4128
引用
收藏
页数：2
相关论文